Anti-Viral Therapies Market Potential Growth, Share, Demand and Analysis of Key Players Research Forecasts to 2028
                     Anti-Viral Therapies Market
Antiviral therapy is one of the most exciting 
branches of virology. It entails several strategies 
used to develop antiviral therapy, including 
direct-acting antivirals that target viral proteins, 
enzymes, or nucleic acids; passive antibodies 
that neutralize viruses circulating in drug; and 
drugs that target cellular proteins or processes 
essential for viral replication.The global anti - 
viral therapies market is driven by factors 
such as increasing R&D expenditures by 
pharmaceutical companies, and rising 
government support for research activities and 
clinical trials. However, the high cost of drug 
development may hinder the market growth.
Anti-Viral Therapies Market
Current and future Market Scenario
 The anti - viral therapies market is expected to reach US$ 76,282.63 million by 2027 from US$ 40,589.79 million in 2019; 
the market is estimated to grow at a CAGR of 8.3% from 2020 to 2027.
 US Food and Drug Administration (USFDA) revealed that it awarded 12 new clinical trial research grants of more than 
US$ 15 million in total, for the period 2020–2023, to improve the development of medical products for patients with rare 
diseases. 
 COVID-19 vaccine development has attained high pace due to large number of participants focusing on clinical trials and 
collaborations to make certain rapid growth and sufficient production capacity. 
 The biotech industry in Europe is playing a vital part in the fight against COVID-19, in terms of developing vaccines, 
therapeutic drugs, diagnostics, and research. For instance, the European Commission offered US$ 105.8 million (EUR 89 
million) to CureVac for the development of COVID-19 vaccine, in March 2020.
Key Findings
 The key findings and recommendations highlight crucial progressive industry trends in the global anti - viral therapies 
market, thereby allowing players across the value chain to develop effective long-term strategies.
 Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in 
the anti - viral therapies market.
 Highlights key business priorities in order to assist companies to realign their business strategies.
Market Insights
Rising Government Support for Research Activities and Clinical Trials
The clinical trials industry has seen exceptional growth in the last 10 years. In August 2019, the US Food and Drug 
Administration (USFDA) revealed that it awarded 12 new clinical trial research grants of more than US$ 15 million in total, 
for the period 2020–2023, to improve the development of medical products for patients with rare diseases. The grants 
were conferred to principal investigators from industry and academics across the country. The FDA awarded the grants 
through the Orphan Products Clinical Trials Grants Program, which is funded by Congress to promote the clinical 
development of medical foods, biologics, drugs, and medical devices for the treatment of rare diseases. The grants are 
intended to considerably contribute to the marketing approval of products to treat rare diseases and provide essential 
data for the development of such products. 
Anti-Viral Therapies Market
Market Segments
Global Anti - Viral Therapies Global Anti - Viral Therapies 
By Product Market– By Mechanism of Action
Market– By Application
(HIV
(generic drugs and branded drugs) (Nucleotide Polymerase Inhibitors Hepatitis
Reverse Transcriptase Inhibitors Herpes
Protease Inhibitors Virus Influenza
Others) Other Applications)
Anti-Viral Therapies Market
Dominating Segments
 Antiviral therapy is one of the most exciting branches of virology. It entails several strategies used to develop 
antiviral therapy, including direct-acting antivirals that target viral proteins, enzymes, or nucleic acids; passive 
antibodies that neutralize viruses circulating in drug; and drugs that target cellular proteins or processes 
essential for viral replication.
 The global anti - viral therapies market is driven by factors such as increasing R&D expenditures by 
pharmaceutical companies, and rising government support for research activities and clinical trials. However, 
the high cost of drug development may hinder the market growth. Additionally, emerging markets are 
creating growth opportunities for the market players.
Dominating Segments
 Mechanism of Action-Based Insights
Based on function, the anti - viral therapies market is segmented into nucleotide polymerase inhibitor, reverse 
transcriptase inhibitors, protease inhibitors, and others. The nucleotide polymerase inhibitor segment held the largest 
share of the market in 2019. However, the reverse transcriptase inhibitors segment is estimated to register the highest 
CAGR in the market during the forecast period.
 
 Application-Based Insights
Based on application, the anti - viral therapies market is segmented into HIV, hepatitis, herpes, virus influenza, and 
other applications. The HIV segment held the largest share of the market in 2019, and the hepatitis segment is 
estimated to register the highest CAGR in the market during the forecast period.
 Download PDF Brochure : https://www.theinsightpartners.com/sample/TIPRE00012650/ 
Dominating Segments
Global Anti - Viral Therapies Market– ByType
Generic Drugs
Branded Drugs
 
Global Anti - Viral Therapies Market– By Mechanism of Action
 
Nucleotide Polymerase Inhibitors
Reverse Transcriptase Inhibitors
Protease Inhibitors
Others
Dominating Segments
Global Anti - Viral Therapies Market– By Application
 
HIV
Hepatitis
Herpes
Virus Influenza
Other Applications
Anti-Viral Therapies Market
Leading Players
Company Profiles in OTC Braces and Support Market are:
AbbVie Inc.
Abbott
F. Hoffmann-La Roche Ltd
Bristol-Myers Squibb Company
Johnson & Johnson Services, Inc.
Merck & Co., Inc.
Gilead Sciences, Inc.
GlaxoSmithKline plc
Aurobindo Pharma
AstraZeneca
  REGIONAL FRAMEWORK
REGIONAL FRAMEWORK
  Anti-Viral Therapies Market 
 
 
Anti-Viral Therapies Market 
 
        
Access Full Research Report at: 
https://www.theinsightpartners.com/reports/anti-viral-therapies-market  
 
Thank You! 
Thank You!